Avalo Therapeutics, Inc. — Director's Dealing 2021

Apr 2, 2021

SEC Form 4/A — Form 4/A

Issuer: Cerecor Inc. (CERC)
CIK: 0001534120
Period of Report: 2021-03-31

Reporting Person: Miller Joseph M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-03-31	Stock Option (Right to Buy)	$3.02	A	5564	Acquired	2031-03-31	Common Stock (5564)	Direct

Footnotes

F1: 100% of this stock option will immediately vest on the date that it is granted.